Literature DB >> 29059597

Justification and authority in institutional review board decision letters.

Justin T Clapp1, Katharine A Gleason2, Steven Joffe3.   

Abstract

While ethnographic study has described the discussions that occur during human subjects research ethics review, investigators have minimal access to the interactions of ethics oversight committees. They instead receive letters stipulating changes to their proposed studies. Ethics committee letters are central to the practice of research ethics: they change the nature of research, alter the knowledge it produces, and in doing so construct what ethical research is and how it is pursued. However, these letters have rarely been objects of analysis. Accordingly, we conducted a qualitative analysis of letters written by American institutional review boards (IRBs) overseeing biomedical and health behavioral research. We sought to clarify how IRBs exercise their authority by assessing the frequency with which they provided reasons for their stipulations as well as the nature of these reasons. We found that IRBs frequently do not justify their stipulations; rather, they often leave ethical or regulatory concerns implicit or frame their comments as boilerplate language replacements, procedural instructions, or demands for missing information. When they do provide justifications, their rationales exhibit substantial variability in explicitness and clarity. These rhetorical tendencies indicate that the authority of IRBs is grounded primarily in their role as bureaucratic gatekeepers. We conclude by suggesting that greater attention to justification could help shift the basis of the IRB-researcher relationship from compliance to mutual accountability.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Authority; Bureaucracy; Ethics review; Human subjects research; Institutional review board (IRB); Research ethics committee (REC); USA

Mesh:

Year:  2017        PMID: 29059597     DOI: 10.1016/j.socscimed.2017.10.013

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool.

Authors:  Lisa Rooney; Laura Covington; Andrea Dedier; Birdena Samuel
Journal:  J Empir Res Hum Res Ethics       Date:  2019-04       Impact factor: 1.742

2.  Reimagining IRB review to incorporate a clear and convincing standard of evidence.

Authors:  E Smith; E E Anderson
Journal:  Account Res       Date:  2021-02-08       Impact factor: 2.622

3.  Standards of evidence for institutional review board decision-making.

Authors:  David B Resnik
Journal:  Account Res       Date:  2020-12-08       Impact factor: 3.057

4.  Insights into the perception that research ethics committees are a barrier to research with seriously ill children: A study of committee minutes and correspondence with researchers studying seriously ill children.

Authors:  Ashleigh E Butler; Katherine Vincent; Myra Bluebond-Langner
Journal:  Palliat Med       Date:  2019-11-04       Impact factor: 4.762

5.  Ethics review of big data research: What should stay and what should be reformed?

Authors:  Agata Ferretti; Marcello Ienca; Mark Sheehan; Alessandro Blasimme; Edward S Dove; Bobbie Farsides; Phoebe Friesen; Jeff Kahn; Walter Karlen; Peter Kleist; S Matthew Liao; Camille Nebeker; Gabrielle Samuel; Mahsa Shabani; Minerva Rivas Velarde; Effy Vayena
Journal:  BMC Med Ethics       Date:  2021-04-30       Impact factor: 2.652

6.  Ethics review, reflective equilibrium and reflexivity.

Authors:  Julie Morton
Journal:  Nurs Ethics       Date:  2021-07-28       Impact factor: 2.874

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.